文献速递主动脉疾病

胸部分支内假体治疗主动脉弓病变的北欧多中心早期结果

Early Outcomes of Thoracic Branch Endoprosthesis in Aortic Arch Pathologies: A Nordic Multicentre Study.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2026-10-22

OBJECTIVE: This study evaluated the feasibility and early clinical outcomes of the Gore thoracic branch endoprosthesis (TBE) in the treatment of aortic arch pathologies.…

要点

  • TBE治疗主动脉弓病变技术成功率高(95%),早期无卒中或脊髓缺血。
  • 随访期内内漏发生率19%,需重视术后持续监测。
  • 早期非计划再干预率6%,提示患者选择与随访策略的重要性。

核心结论

  • TBE在多种主动脉弓病变中显示高技术成功率和可接受的早期结局。
  • 内漏发生率相对较高且需早期再干预,强调谨慎患者选择和密切术后监测的重要性。

研究设计与样本

  • 多中心回顾性研究,遵循STROBE声明。
  • 中位年龄73岁(四分位距59,77),男性占69%。
  • 不限制主动脉疾病类型或范围、分期手术或同期辅助腔内干预。

主要发现

  • 治疗指征包括退行性动脉瘤26例(41%)、慢性夹层18例(28%)、亚急性夹层11例(17%)、急性夹层9例(14%)。
  • 目标血管为左锁骨下动脉59例(92%)、头臂干3例(5%)、左颈总动脉2例(3%)。
  • 技术成功61例(95%),失败原因为2例Ia型内漏和1例IIIa型内漏。
  • 无卒中或脊髓缺血发生,中位随访6个月(2,10),无晚期死亡,所有分支原发通畅率100%。

临床怎么用

  • TBE可用于退行性动脉瘤、慢性/亚急性/急性夹层等主动脉弓病变的腔内治疗。
  • 术后需密切监测内漏,尤其Ia型内漏,并警惕早期再干预可能。

局限性

  • 回顾性研究设计。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study evaluated the feasibility and early clinical outcomes of the Gore thoracic branch endoprosthesis (TBE) in the treatment of aortic arch pathologies. METHODS: This multicentre retrospective study, conducted and reported in accordance with the STROBE statement, included consecutive patients undergoing thoracic endovascular aortic repair with TBE between February 2024 and July 2025. No restrictions were applied regarding the type or extent of aortic disease, use of staged procedures, or concomitant adjunctive endovascular interventions. Primary endpoints were technical success, thirty day mortality, and overall survival, while endoleak occurrence, primary target vessel patency, stroke, and spinal cord ischaemia (SCI) were secondary. RESULTS: Sixty-four patients (median age 73 years [interquartile range 59, 77]; 69% men) were included. Indications for treatment included degenerative aneurysm (n = 26; 41%), chronic dissection (n = 18; 28%), subacute dissection (n = 11; 17%), and acute dissection (n = 9; 14%). The left subclavian artery was the target vessel in 59 cases (92%), followed by the brachiocephalic trunk in three (5%) and the left common carotid artery in two (3%). Technical success was achieved in 95% of cases (n = 61), with failures attributed to two type Ia endoleaks and one type IIIa endoleak. Thirty day mortality was 3% (n = 2). Early unplanned re-interventions occurred in four patients (6%). No strokes or SCI were observed. Median follow up was 6 months (2, 10). No late mortality was observed, and primary patency of all branches was 100%. One late unplanned re-intervention, unrelated to the TBE device, was required. During follow up, 12 patients (19%) had endoleaks, including type II (n = 4), type Ia (n = 4), type Ib (n = 2), type III (n = 1), and type V (n = 1). Estimated freedom from type Ia endoleak at 12 months was 93 ± 3%, while estimated overall survival at 12 months was 97 ± 2%. CONCLUSION: TBE demonstrated high technical success and acceptable early outcomes across a range of aortic arch pathologies. However, the relatively high rate of endoleaks and need for early re-interventions highlight the importance of careful patient selection and close continuous post-operative surveillance.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Karelis A, Asciutto G, Jonsson M, et al. Early Outcomes of Thoracic Branch Endoprosthesis in Aortic Arch Pathologies: A Nordic Multicentre Study. Eur J Vasc Endovasc Surg. 2026. PMID: 42913781. doi:10.1016/j.ejvs.2026.10.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。